AbCellera Biologics Inc. ABCL Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- AbCellera Biologics Inc. (ABCL) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of $3.08M in Q4 2025.
- How has AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
- AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount decreased by 19.0% year-over-year, from $3.8M to $3.08M.
- What is the long-term trend for AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 3.6% compound annual growth rate (CAGR), from $11.49M to $12.32M.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
- Measures the adjustment to the valuation allowance for deferred tax assets, reflecting management's assessment of the likelihood that these assets will be realized. A significant change indicates a shift in the company's outlook regarding future taxable income.